skinfusion

4 stories · following the connections

Business

Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock

By Nasdaq OMXAug 3, 2017, 12:24 PM UTC

Business

Agile Therapeutics Announces Proposed Offering of Common Stock

By Nasdaq OMXAug 2, 2017, 8:06 PM UTC

Business

Agile Therapeutics Reports Second Quarter 2017 Financial Results

By Nasdaq OMXJul 28, 2017, 11:30 AM UTC

Business

Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®

By Nasdaq OMXJul 27, 2017, 8:12 PM UTC